论文部分内容阅读
目的 探讨益气活血方在食管癌患者放化疗中的作用。方法 31例行放疗和介入化疗(A组)与31例行放疗、介入化疗、益气活血方并用(B组)进行比较。结果 A、B两组近期有效率为484%、645%(P>0.05),B组骨髓功能明显高于A组(P<0.05)。1年转移率A组高于B组(P<0.05),远期生存率B组明显高于A组(P<0.05)。结论 本方能减轻放化疗造成的骨髓抑制,降低转移率,延长远期生存率,改善生活质量。
Objective To explore the effect of Yiqi Huoxue Fang in the treatment of esophageal cancer patients with radiotherapy and chemotherapy. Methods 31 Routine radiotherapy and interventional chemotherapy (group A) were compared with 31 patients who underwent radiotherapy, interventional chemotherapy and Yiqihuoxue decoction (group B). Results The effective rates of A and B in the two groups were 484% and 645% (P>0.05). The bone marrow function in group B was significantly higher than that in group A (P<0.05). The 1-year metastasis rate in group A was higher than that in group B (P<0.05). The long-term survival rate in group B was significantly higher than that in group A (P<0.05). Conclusion This method can reduce myelosuppression caused by radiotherapy and chemotherapy, reduce the metastasis rate, prolong the long-term survival rate, and improve the quality of life.